Mutational networks of escape from transmitted HIV-1 infection
Mutational networks of escape from transmitted HIV-1 infection
Human immunodeficiency virus (HIV) is subject to immune selective pressure soon after it establishes infection at the founder stage. As an individual progresses from the founder to chronic stage of infection, immune pressure forces a history of mutations that are embedded in envelope sequences. Determining this pathway of coevolving mutations can assist in understanding what is different with the founder virus and the essential pathways it takes to maintain infection. We have combined operations research and bioinformatics methods to extract key networks of mutations that differentiate founder and chronic stages for 156 subtype B and 107 subtype C envelope (gp160) sequences. The chronic networks for both subtypes revealed strikingly different hub-and-spoke topologies compared to the less structured transmission networks. This suggests that the hub nodes are impacted by the immune response and the resulting loss of fitness is compensated by mutations at the spoke positions. The major hubs in the chronic C network occur at positions 12, 137 (within the N136 glycan), and 822, and at position 306 for subtype B. While both founder networks had a more heterogeneous connected network structure, interestingly founder B subnetworks around positions 640 and 837 preferentially contained CD4 and coreceptor binding domains. Finally, we observed a differential effect of glycosylation between founder and chronic subtype B where the latter had mutational pathways significantly driven by N-glycosylation. Our study provides insights into the mutational pathways HIV takes to evade the immune response, and presents features more likely to establish founder infection, valuable for effective vaccine design.
- UNSW Sydney Australia
- University of Exeter United Kingdom
Glycosylation, Science, Q, R, Immunity, env Gene Products, Human Immunodeficiency Virus, 610, Computational Biology, HIV Infections, HIV Envelope Protein gp160, Mutation, HIV-1, Medicine, Humans, Research Article, Immune Evasion, Protein Binding
Glycosylation, Science, Q, R, Immunity, env Gene Products, Human Immunodeficiency Virus, 610, Computational Biology, HIV Infections, HIV Envelope Protein gp160, Mutation, HIV-1, Medicine, Humans, Research Article, Immune Evasion, Protein Binding
22 Research products, page 1 of 3
- 2011IsRelatedTo
- 2017IsRelatedTo
- 2014IsRelatedTo
- 2019IsRelatedTo
- 2017IsRelatedTo
- 2013IsRelatedTo
- 2015IsRelatedTo
- 2017IsRelatedTo
- 2014IsRelatedTo
chevron_left - 1
- 2
- 3
chevron_right
22 bioentities, page 1 of 2
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).1 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
